#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	11964	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2030	580.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	661	C	652	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21564	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3651	588.1	0	.	n	.	0	T695C	SNP	695	695	T	1121	1121	C	605	C	593	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21564	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3651	588.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1763	1763	A	684	A	665	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21564	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3651	588.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2397	2397	C	705	C,T,A	688,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21564	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3651	588.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3023	3023	T	615	T	610	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21564	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3651	588.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2471	2471	A	700	A	686	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1516	folP	852	852	100.0	folP.l15.c17.ctg.1	1469	102.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1009	1011	AGC	147;146;146	A,G;G;C	141,1;142;140	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4526	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3357	134.0	1	SNP	p	S91F	0	.	.	271	273	TCC	542	544	TCC	160;160;161	T;C;C	155;157;158	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4526	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3357	134.0	1	SNP	p	D95G	0	.	.	283	285	GAC	554	556	GAC	160;159;159	G;A;C	158;152;156	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4526	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3357	134.0	1	SNP	p	D95N	0	.	.	283	285	GAC	554	556	GAC	160;159;159	G;A;C	158;152;156	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1338	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1363	97.7	0	.	p	.	0	A39T	NONSYN	115	117	GCC	439	441	ACC	138;136;136	A;C;C	129;134;132	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1338	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1363	97.7	0	.	p	.	0	R44H	NONSYN	130	132	CGC	454	456	CAC	131;131;133	C,G;A;C	127,1;124;130	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1338	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1363	97.7	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	637	639	CAC	159;159;161	C;A;C	155;154;157	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1338	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1363	97.7	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	136;136;136	G;G;C	134;132;132	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	744	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1022	72.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3049	129.9	1	SNP	p	D86N	0	.	.	256	258	GAC	666	668	GAC	157;156;156	G;A;C	156;150;155	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3049	129.9	1	SNP	p	S87W	0	.	.	259	261	AGT	669	671	AGT	153;154;154	A;G;T	151;153;151	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3049	129.9	1	SNP	p	S87I	0	.	.	259	261	AGT	669	671	AGT	153;154;154	A;G;T	151;153;151	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3049	129.9	1	SNP	p	S87R	0	.	.	259	261	AGT	669	671	AGT	153;154;154	A;G;T	151;153;151	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3980	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3049	129.9	1	SNP	p	S88P	0	.	.	262	264	TCC	672	674	TCC	154;154;155	T;C;C	154;152;152	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3430	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2572	132.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1531	1533	GGC	165;164;162	G;G;C	160;160;154	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1294	1296	GCA	176;178;179	G;C;A	172;169;176	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1297	1299	ATC	180;182;184	A;T;C	178;178;180	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1309	1311	GTG	186;188;189	G;T;G	183;179;185	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1309	1311	GTG	186;188;189	G;T;G	183;179;185	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1813	1815	ACC	132;130;129	A;C;C	123;127;126	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1867	1869	GCG	133;134;133	G;C,G;G,C	127;116,1;121,2	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1867	1869	GCG	133;134;133	G;C,G;G,C	127;116,1;121,2	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1990	1992	GGC	113;111;111	G;G;C,T	110;110;106,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1999	2001	GGC	109;109;107	G;G;C	107;106;105	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3110	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2484	124.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2017	2019	CCG	79;79;79	C,G;C,G;G	73,1;73,1;67	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4636	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3209	143.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1962	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1786	108.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	556	556	C	125	C	117	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	0	.	p	.	0	E48G	NONSYN	142	144	GAA	497	499	GGA	190;190;193	G;G,A;A	187;186,1;189	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	0	.	p	.	0	F135L	NONSYN	403	405	TTT	758	760	CTT	182;182;184	C,G;T;T,G	176,1;176;175,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	0	.	p	.	0	R143G	NONSYN	427	429	AGA	782	784	GGA	181;179;177	G,A;G,A;A,C	176,1;175,1;169,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	0	.	p	.	0	D171G	NONSYN	511	513	GAT	866	868	GGT	162;164;163	G;G;T	157;163;153	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	0	.	p	.	0	G189S	NONSYN	565	567	GGC	920	922	AGC	185;186;184	A;G;C	181;182;181	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	986	986	T	164	T	158	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	1	SNP	p	G120K	0	.	.	358	360	GGT	713	715	GGT	188;185;187	G;G;T	185;184;178	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	1	SNP	p	A121N	0	.	.	361	363	GCC	716	718	GCC	186;185;184	G;C,A;C	182;179,1;180	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2256	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1597	140.4	1	SNP	p	A121D	0	.	.	361	363	GCC	716	718	GCC	186;185;184	G;C,A;C	182;179,1;180	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8168	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4839	167.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2004	2006	AAT	174;176;177	A,C;A;T	169,1;172;172	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	944	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1048	89.3	1	SNP	p	V57M	1	.	.	169	171	ATG	516	518	ATG	169;170;173	A;T;G,A	166;166;169,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
